🇧🇷 Slynd in Brazil

Slynd (DROSPIRENONE) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Slynd in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Dermatology approved in Brazil

Frequently asked questions

Is Slynd approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Slynd in Brazil?

Exeltis Usa Inc is the originator. The local marketing authorisation holder may differ — check the official source linked above.